Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis
Authors:
- Fabrice AndréFAFabrice André
- Stefan MichielsSMStefan Michiels
- Philippe DessenPDPhilippe Dessen
- Veronique ScottVSVeronique Scott
- Voichita SuciuVSVoichita Suciu
- Catherine UzanCUCatherine Uzan
- Vladimir LazarVLVladimir Lazar
- Ludovic LacroixLLLudovic Lacroix
- Gilles VassalGVGilles Vassal
- Marc SpielmannMSMarc Spielmann
- Philippe VielhPVPhilippe Vielh
- Suzette DelalogeSDSuzette Delaloge
- 1 April 2009
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 10 (4) , 381-390
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic GradeJournal of Clinical Oncology, 2007
- Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast CancerJournal of Clinical Oncology, 2006
- B-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancerJournal of Clinical Investigation, 2005
- Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancerProceedings of the National Academy of Sciences, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumorsJournal of Clinical Investigation, 2005
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Molecular portraits of human breast tumoursNature, 2000